CS MEDICA

CS MEDICA announces today that the trademark offices in Australia have approved CS MEDICA’s trademark CANNASEN^®.

“One of the things to secure when building a global business is trademarks. CS MEDICA has always been active in filing patents to secure the future of our products, but we also see the value of securing our brands with trademark registration. This is an additional important step we are taking in our global sales strategy.” says CEO Lone Henriksen.

The trademark approval of CANNASEN^® is an important step in CS MEDICA's market strategy to expand sales of its product line CANNASEN^® in the global market. The trademark registration no. for CANNASEN^® in Australia is 2233150 and is valid until November 19, 2028.

Trademarks as of October 2023;